Pagliaro P, Penna C
Department of Clinical and Biological Sciences, University of Torino, 10043, Orbassano, Turin, Italy.
Br J Pharmacol. 2015 Apr;172(8):1974-95. doi: 10.1111/bph.12975. Epub 2015 Jan 12.
The morbidity and mortality from coronary artery disease (CAD) remain significant worldwide. The treatment for acute myocardial infarction has improved over the past decades, including early reperfusion of culprit coronary arteries. Although it is mandatory to reperfuse the ischaemic territory as soon as possible, paradoxically this leads to additional myocardial injury, namely ischaemia/reperfusion (I/R) injury, in which redox stress plays a pivotal role and for which no effective therapy is currently available. In this review, we report evidence that the redox environment plays a pivotal role not only in I/R injury but also in cardioprotection. In fact, cardioprotective strategies, such as pre- and post-conditioning, result in a robust reduction in infarct size in animals and the role of redox signalling is of paramount importance in these conditioning strategies. Nitrosative signalling and cysteine redox modifications, such as S-nitrosation/S-nitrosylation, are also emerging as very important mechanisms in conditioning cardioprotection. The reasons for the switch from protective oxidative/nitrosative signalling to deleterious oxidative/nitrosative/nitrative stress are not fully understood. The complex regulation of this switch is, at least in part, responsible for the diminished or lack of cardioprotection induced by conditioning protocols observed in ageing animals and with co-morbidities as well as in humans. Therefore, it is important to understand at a mechanistic level the reasons for these differences before proposing a safe and useful transition of ischaemic or pharmacological conditioning. Indeed, more mechanistic novel therapeutic strategies are required to protect the heart from I/R injury and to improve clinical outcomes in patients with CAD.
在全球范围内,冠状动脉疾病(CAD)的发病率和死亡率仍然很高。在过去几十年中,急性心肌梗死的治疗方法有了改进,包括对罪犯冠状动脉的早期再灌注。尽管尽快对缺血区域进行再灌注是必要的,但矛盾的是,这会导致额外的心肌损伤,即缺血/再灌注(I/R)损伤,氧化还原应激在其中起关键作用,目前尚无有效的治疗方法。在这篇综述中,我们报告了证据表明氧化还原环境不仅在I/R损伤中起关键作用,而且在心脏保护中也起关键作用。事实上,心脏保护策略,如预处理和后处理,可使动物梗死面积显著减小,氧化还原信号在这些预处理策略中的作用至关重要。亚硝化信号和半胱氨酸氧化还原修饰,如S-亚硝基化/ S-亚硝基化,也正在成为预处理心脏保护中非常重要的机制。从保护性氧化/亚硝化信号转变为有害的氧化/亚硝化/硝化应激的原因尚未完全了解。这种转变的复杂调节至少部分地导致了在衰老动物、患有合并症的动物以及人类中观察到的预处理方案诱导的心脏保护作用减弱或缺乏。因此,在提出安全有效的缺血或药物预处理转变之前,从机制层面了解这些差异的原因很重要。确实,需要更多基于机制的新型治疗策略来保护心脏免受I/R损伤,并改善CAD患者的临床结局。